Neurogen neurogen.com


Neurogen is both in the discovery and development of new drug candidates and in the development and integration of new drug-discovery technology, most notably its AIDD (Accelerated Intelligent Drug Discovery) system. Neurogen's new drug programs promise improved efficacy and reduced side effects in treating psychiatric, metabolic and inflammatory disorders.

Neurogen is both in the discovery and development of new drug candidates and in the development and integration of new drug-discovery technology, most notably its AIDD (Accelerated Intelligent Drug Discovery) system. Neurogen's new drug programs prom...Show all

Company (Acquired)

Phone: 203-488-8201

Fax:

45 Northeast Industrial Road

Branford, 06405
Connecticut, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Neurogen $171.6M Aug 18, 2009
Threshold Pharmaceuticals $106.4M Aug 18, 2008
Innoviva $257.7M Oct 5, 2004
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Neurogen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Dipiperazinyl ketones and related analogues Jul 28, 2006 Dec 14, 2010 Patent
Substituted quinolin-4-ylamine analogues Jul 14, 2004 Feb 10, 2009 Patent